Sorrento Therapeutics Stock Price, News & Analysis
SRNE
OTC Link
Company Description
Welcome to the overview page for Sorrento Therapeutics (SRNE), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$0.0015
0.00%
0.00
Last updated: August 3, 2025 at 15:53
- %
Performance 1 year
$385.9K
Market Cap
551.3M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Sorrento Therapeutics.
Financial Highlights
$62,839,000
Revenue (TTM)
-$577,757,000
Net Income (TTM)
-$1.37
Diluted EPS (TTM)
-$293,857,000
Operating Cash Flow
-919.42%
Net Profit Margin
-802.55%
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Sorrento Therapeutics (SRNE)?
The current stock price of Sorrento Therapeutics (SRNE) is $0.0015 as of August 1, 2025.
What is the market cap of Sorrento Therapeutics (SRNE)?
The market cap of Sorrento Therapeutics (SRNE) is approximately 385.9K.
What is the revenue (TTM) of Sorrento Therapeutics (SRNE) stock?
The trailing twelve months (TTM) revenue of Sorrento Therapeutics (SRNE) is $62,839,000.
What is the net income of Sorrento Therapeutics (SRNE)?
The trailing twelve months (TTM) net income of Sorrento Therapeutics (SRNE) is -$577,757,000.
What is the earnings per share (EPS) of Sorrento Therapeutics (SRNE)?
The diluted earnings per share (EPS) of Sorrento Therapeutics (SRNE) is -$1.37 on a trailing twelve months (TTM) basis.
What is the operating cash flow of Sorrento Therapeutics (SRNE)?
The operating cash flow of Sorrento Therapeutics (SRNE) is -$293,857,000.
What is the profit margin of Sorrento Therapeutics (SRNE)?
The net profit margin of Sorrento Therapeutics (SRNE) is -919.42%.
What is the operating margin of Sorrento Therapeutics (SRNE)?
The operating profit margin of Sorrento Therapeutics (SRNE) is -802.55%.
What is the current ratio of Sorrento Therapeutics (SRNE)?
The current ratio of Sorrento Therapeutics (SRNE) is 0.29, indicating the company's ability to pay short-term obligations.
What is the operating income of Sorrento Therapeutics (SRNE)?
The operating income of Sorrento Therapeutics (SRNE) is -$504,315,000.